Overview

Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
This study will assess an investigational medication for patients with chronic renal insufficiency (pre-dialysis) who have secondary hyperparathyroidism.
Phase:
Phase 2
Details
Lead Sponsor:
Amgen
Treatments:
Cinacalcet
Cinacalcet Hydrochloride